Nicholas Investment Partners, LP - KARUNA THERAPEUTICS INC ownership

KARUNA THERAPEUTICS INC's ticker is KRTX and the CUSIP is 48576A100. A total of 201 filers reported holding KARUNA THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 1.18 and the average weighting 0.9%.

Quarter-by-quarter ownership
Nicholas Investment Partners, LP ownership history of KARUNA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$15,573,358
-53.9%
92,101
-40.9%
1.16%
-49.7%
Q2 2023$33,813,420
+19.5%
155,930
+0.1%
2.31%
+7.5%
Q1 2023$28,303,508
+48.3%
155,822
+60.4%
2.15%
+28.6%
Q4 2022$19,085,652
+9.8%
97,128
+25.7%
1.67%
+3.8%
Q3 2022$17,377,000
+146.3%
77,254
+38.5%
1.61%
+141.5%
Q2 2022$7,054,000
+175.5%
55,761
+176.2%
0.67%
+266.5%
Q1 2022$2,560,00020,1890.18%
Other shareholders
KARUNA THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Pivotal bioVenture Partners Investment Advisor LLC 797,008$134,766,08353.75%
Nan Fung Group Holdings Ltd 225,688$38,161,58430.90%
Sofinnova Investments, Inc. 1,381,149$233,538,48414.73%
First Light Asset Management, LLC 303,137$51,257,4354.87%
Altium Capital Management LP 34,000$5,749,0603.00%
DAFNA Capital Management LLC 52,873$8,940,2962.78%
Logos Global Management LP 115,000$19,445,3502.59%
GENERAL ATLANTIC, L.P. 986,710$166,842,7942.58%
MPM BioImpact LLC 53,210$8,997,2792.40%
Rock Springs Capital Management LP 505,433$85,463,6662.29%
View complete list of KARUNA THERAPEUTICS INC shareholders